Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: November 27, 2024 Report Code: GDME1892EPD-ST

Select Item

Therapeutic Drug Monitoring Pipeline Market Report Overview

Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair, and sweat. The therapeutic drug monitoring pipeline market research report covers comprehensive information about the pipeline products with their comparative analysis at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Segments ·       Immunosuppressant Therapeutic Drug Monitoring

·       Antibiotic/Antivirus Therapeutic Drug Monitoring

·       Central Nervous Systems Therapeutic Drug Monitoring

·       Cardiovascular Therapeutic Drug Monitoring
Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Australia
Key Regulatory Paths ·       510(k)

·       CE-IVD

·       MDITAC

·       Ninsho

·       TGA
Leading Companies ·       20/20 GeneSystems Inc

·       Abbott Diagnostics

·       Adaptive Biotechnologies Corp

·       Affinergy LLC

·       Age Labs AS
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Therapeutic Drug Monitoring Pipeline Market Segments

The key segments in the therapeutic drug monitoring pipeline market are immunosuppressant therapeutic drug monitoring, antibiotic/antivirus therapeutic drug monitoring, central nervous systems therapeutic drug monitoring, and cardiovascular therapeutic drug monitoring. As of November 2024, immunosuppressant therapeutic drug monitoring accounted for the highest number of pipeline products.

Therapeutic Drug Monitoring Pipeline Market Analysis by Segments, 2024 (%)

Therapeutic Drug Monitoring Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segmental Insights into the Therapeutic Drug Monitoring Pipeline Market

Download a Free Report Sample

Therapeutic Drug Monitoring Pipeline Market Segmentation by Territories

The key territories in the therapeutic drug monitoring pipeline market are the US, Europe, China, Japan, and Australia, among others. As of November 2024, the US accounted for the highest number of pipeline products.

Therapeutic Drug Monitoring Pipeline Market Analysis by Territories, 2024 (%)

Therapeutic Drug Monitoring Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Therapeutic Drug Monitoring Pipeline Market

Download a Free Report Sample

Therapeutic Drug Monitoring Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the therapeutic drug monitoring pipeline products market are 510(k), CE-IVD, MDITAC, Ninsho, and TGA among others. As of November 2024, 510(k) was the most followed pathway for pipeline products in the therapeutic drug monitoring market.

Therapeutic Drug Monitoring Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Therapeutic Drug Monitoring Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Therapeutic Drug Monitoring Pipeline Market

Download a Free Report Sample

Therapeutic Drug Monitoring Pipeline Market – Competitive Landscape

A few of the leading companies associated with the pacemaker pipeline market are 20/20 GeneSystems Inc, Abbott Diagnostics, Adaptive Biotechnologies Corp, Affinergy LLC, and Age Labs AS.

20/20 GeneSystems Inc: 20/20 GeneSystems Inc (20/20 Gene) carries out the discovery, development, and commercialization of clinical laboratory tests. The company offers products such as BioCheck suspicious powder test kit, corona check test kit and OneTest kit. It conducts clinical lab tests in therapeutic areas such as early detection of various types of cancers, COVID-19 antibody testing, personalized medicine and biological detection.

Abbott Diagnostics: Abbott Diagnostics (Abbott) a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers various core laboratory products, molecular point of care products, transfusion medicine, professional services, and diagnostics. Abbott products portfolio include laboratory systems for automationmolecular diagnostic systems and point of care systems for blood analysis.

Therapeutic Drug Monitoring Pipeline Market Analysis by Companies, 2024

Therapeutic Drug Monitoring Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Therapeutic Drug Monitoring Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Therapeutic Drug Monitoring Pipeline Market Segments Outlook (2024)

  • Immunosuppressant Therapeutic Drug Monitoring
  • Antibiotic/Antivirus Therapeutic Drug Monitoring
  • Central Nervous Systems Therapeutic Drug Monitoring
  • Cardiovascular Therapeutic Drug Monitoring

Therapeutic Drug Monitoring Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • Australia

Therapeutic Drug Monitoring Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • MDITAC
  • Ninsho
  • TGA

Scope

This report provides:

  • Extensive coverage of the Therapeutic Drug Monitoring under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Therapeutic Drug Monitoring and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

  • Identify and understand important and diverse types of Therapeutic Drug Monitoring under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

20/20 GeneSystems Inc
Abbott Diagnostics
Adaptive Biotechnologies Corp
Affinergy LLC
Age Labs AS
Animated Dynamics Inc
Applied Research using OMIC Sciences SL
ARK Diagnostics Inc
Avacta Group Plc
BG Medicine Inc
BIOHOPE Scientific SL
Boston University
CCC Diagnostics LLC
Centre Hospitalier Universitaire de Nice
Chronix Biomedical Inc
Cognizance Biomarkers LLC
Columbia University
ContraVac Inc (Inactive)
Denovo Biolabs Pvt Ltd
DNAPrint Genomics Inc (Inactive)
Dublin City University
Ecole Polytechnique Federale de Lausanne
ELITechGroup Inc
Eurobio Scientific SA
Gene Express, Inc. (Inactive)
GenMark Diagnostics Inc
GlucoSentient Inc
HORIBA ABX SAS
Inflammatix Inc
Instrumentation Laboratory Co (Inactive)
Johns Hopkins University
Magnasense AB
McMaster University
Medical Research Council
Metabolon Inc
Newcastle University
Nipro Europe N.V.
Nuclea Biotechnologies Inc. (Inactive)
PanGenomic Health Inc
Pax Neuroscience Inc
Pelago Bioscience AB
Pennsylvania State University
Plateletdiagnostics LLC
Prediction Sciences LLC (Inactive)
Prescient Medical Inc
Progenika Biopharma SA
Prometheus Laboratories Inc
Proteomika (Inactive)
Purdue University
Queen Mary University of London
Roche Diagnostics Corp
Roche Diagnostics International Ltd
Rockland Immunochemicals Inc
SAGA Diagnostics AB
Saladax Biomedical Inc
Sanofi
Siemens Healthcare Diagnostics Inc
Sirius Genomics Inc
Spanish National Research Council
SQI Diagnostics Inc
T2 Biosystems Inc
Thermo Fisher Scientific Inc
TrivarX Ltd
Universidade Feevale
University of Colorado
University of Colorado Denver
University of North Dakota
University of Queensland
University of Sao Paulo
University of Utah
University of Washington
Vesynta Ltd
Vyant Bio Inc (Inactive)
Zymeron Corp

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Therapeutic Drug Monitoring Overview

3 Products under Development

3.1 Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

3.2 Therapeutic Drug Monitoring – Pipeline Products by Segment

3.3 Therapeutic Drug Monitoring – Pipeline Products by Territory

3.4 Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path

3.5 Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date

3.6 Therapeutic Drug Monitoring – Ongoing Clinical Trials

4 Therapeutic Drug Monitoring – Pipeline Products under Development by Companies

4.1 Therapeutic Drug Monitoring Companies – Pipeline Products by Stage of Development

4.2 Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

5 Therapeutic Drug Monitoring Companies and Product Overview

5.1 20/20 GeneSystems Inc Company Overview

5.1.1 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Abbott Diagnostics Company Overview

5.2.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

5.3 Adaptive Biotechnologies Corp Company Overview

5.3.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview

5.4 Affinergy LLC Company Overview

5.4.1 Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview

5.5 Age Labs AS Company Overview

5.5.1 Age Labs AS Pipeline Products & Ongoing Clinical Trials Overview

5.6 Animated Dynamics Inc Company Overview

5.6.1 Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Applied Research using OMIC Sciences SL Company Overview

5.7.1 Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview

5.8 ARK Diagnostics Inc Company Overview

5.8.1 ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 Avacta Group Plc Company Overview

5.9.1 Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview

5.10 BG Medicine Inc Company Overview

5.10.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 BIOHOPE Scientific SL Company Overview

5.11.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview

5.12 Boston University Company Overview

5.12.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview

5.13 CCC Diagnostics LLC Company Overview

5.13.1 CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.14 Centre Hospitalier Universitaire de Nice Company Overview

5.14.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview

5.15 Chronix Biomedical Inc Company Overview

5.15.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 Cognizance Biomarkers LLC Company Overview

5.16.1 Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview

5.17 Columbia University Company Overview

5.17.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.18 ContraVac Inc (Inactive) Company Overview

5.18.1 ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.19 Denovo Biolabs Pvt Ltd Company Overview

5.19.1 Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.20 DNAPrint Genomics Inc (Inactive) Company Overview

5.20.1 DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.21 Dublin City University Company Overview

5.21.1 Dublin City University Pipeline Products & Ongoing Clinical Trials Overview

5.22 Ecole Polytechnique Federale de Lausanne Company Overview

5.22.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview

5.23 ELITechGroup Inc Company Overview

5.23.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview

5.24 Eurobio Scientific SA Company Overview

5.24.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview

5.25 Gene Express, Inc. (Inactive) Company Overview

5.25.1 Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.26 GenMark Diagnostics Inc Company Overview

5.26.1 GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 GlucoSentient Inc Company Overview

5.27.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview

5.28 HORIBA ABX SAS Company Overview

5.28.1 HORIBA ABX SAS Pipeline Products & Ongoing Clinical Trials Overview

5.29 Inflammatix Inc Company Overview

5.29.1 Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview

5.30 Instrumentation Laboratory Co (Inactive) Company Overview

5.30.1 Instrumentation Laboratory Co (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.31 Johns Hopkins University Company Overview

5.31.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.32 Magnasense AB Company Overview

5.32.1 Magnasense AB Pipeline Products & Ongoing Clinical Trials Overview

5.33 McMaster University Company Overview

5.33.1 McMaster University Pipeline Products & Ongoing Clinical Trials Overview

5.34 Medical Research Council Company Overview

5.34.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview

5.35 Metabolon Inc Company Overview

5.35.1 Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview

5.36 Newcastle University Company Overview

5.36.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview

5.37 Nipro Europe N.V. Company Overview

5.37.1 Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview

5.38 Nuclea Biotechnologies Inc. (Inactive) Company Overview

5.38.1 Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.39 PanGenomic Health Inc Company Overview

5.39.1 PanGenomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.40 Pax Neuroscience Inc Company Overview

5.40.1 Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.41 Pelago Bioscience AB Company Overview

5.41.1 Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview

5.42 Pennsylvania State University Company Overview

5.42.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview

5.43 Plateletdiagnostics LLC Company Overview

5.43.1 Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.44 Prediction Sciences LLC (Inactive) Company Overview

5.44.1 Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.45 Prescient Medical Inc Company Overview

5.45.1 Prescient Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 Progenika Biopharma SA Company Overview

5.46.1 Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview

5.47 Prometheus Laboratories Inc Company Overview

5.47.1 Prometheus Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Proteomika (Inactive) Company Overview

5.48.1 Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.49 Purdue University Company Overview

5.49.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview

5.50 Queen Mary University of London Company Overview

5.50.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview

5.51 Roche Diagnostics Corp Company Overview

5.51.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview

5.52 Roche Diagnostics International Ltd Company Overview

5.52.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.53 Rockland Immunochemicals Inc Company Overview

5.53.1 Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.54 SAGA Diagnostics AB Company Overview

5.54.1 SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

5.55 Saladax Biomedical Inc Company Overview

5.55.1 Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.56 Sanofi Company Overview

5.56.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview

5.57 Siemens Healthcare Diagnostics Inc Company Overview

5.57.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.58 Sirius Genomics Inc Company Overview

5.58.1 Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.59 Spanish National Research Council Company Overview

5.59.1 Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview

5.60 SQI Diagnostics Inc Company Overview

5.60.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.61 T2 Biosystems Inc Company Overview

5.61.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.62 Thermo Fisher Scientific Inc Company Overview

5.62.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

5.63 TrivarX Ltd Company Overview

5.63.1 TrivarX Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.64 Universidade Feevale Company Overview

5.64.1 Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview

5.65 University of Colorado Company Overview

5.65.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

5.66 University of Colorado Denver Company Overview

5.66.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview

5.67 University of North Dakota Company Overview

5.67.1 University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview

5.68 University of Queensland Company Overview

5.68.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview

5.69 University of Sao Paulo Company Overview

5.69.1 University of Sao Paulo Pipeline Products & Ongoing Clinical Trials Overview

5.70 University of Utah Company Overview

5.70.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview

5.71 University of Washington Company Overview

5.71.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.72 Vesynta Ltd Company Overview

5.72.1 Vesynta Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.73 Vyant Bio Inc (Inactive) Company Overview

5.73.1 Vyant Bio Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.74 Zymeron Corp Company Overview

5.74.1 Zymeron Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Therapeutic Drug Monitoring- Recent Developments

6.1 Oct 23, 2024: Thermo Fisher Scientific Announces Q3 2024 Financial Results

6.2 Oct 23, 2024: Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024

6.3 Oct 16, 2024: Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024

6.4 Oct 08, 2024: T2 Biosystems to Host Business Update Call on October 10, 2024

6.5 Oct 07, 2024: Revvity to Hold Earnings Call on Monday, November 4, 2024

6.6 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024

6.7 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024

6.8 Sep 12, 2024: Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024

6.9 Sep 10, 2024: iatricSystems and Renown Health Enhance Drug Diversion Monitoring with AI and Automation

6.10 Aug 01, 2024: Aurinia Pharmaceuticals Announces Results for Q2 and Six Months Ended June 30, 2024

6.11 Jul 18, 2024: Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

6.12 Jul 09, 2024: Revvity to Hold Earnings Call on Monday, July 29, 2024

6.13 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024

6.14 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings

6.15 Jun 26, 2024: Scale Biosciences Announces Scaleplex Technology to Simplify Single Cell Genomics Studies of Any Scale

6.16 Jun 20, 2024: Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024

6.17 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

6.18 Jun 17, 2024: Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

6.19 Jun 14, 2024: Aurinia Announces 2024 Annual General Meeting Results

6.20 Jun 05, 2024: GeneDx Announces Patient Access Program To Expand Access To Exome Testing For Pediatric Epilepsy Patients

6.21 Jun 04, 2024: Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

6.22 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter

6.23 May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference

6.24 May 06, 2024: Decoding Pre-existing Antibodies Towards AAV Capsids to Optimize Gene Therapy Outcomes

6.25 May 02, 2024: DoseMe Enables Precision Dosing at Independence Health System

6.26 May 01, 2024: Natera to Report its First Quarter 2024 Results on May 9

6.27 Apr 24, 2024: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024

6.28 Apr 23, 2024: Acurx Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

6.29 Apr 16, 2024: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference

6.30 Apr 15, 2024: Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024

6.31 Apr 09, 2024: Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference

6.32 Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024

6.33 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics

6.34 Mar 12, 2024: Queen’s Appoints Next Board of Trustees chair

6.35 Mar 04, 2024: Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

6.36 Feb 29, 2024: Metabolon Unveils New Integrated Bioinformatics Platform

6.37 Feb 27, 2024: Aurinia to Participate in Upcoming Investor Healthcare Conferences

6.38 Feb 05, 2024: Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024

6.39 Feb 02, 2024: DoseMe Expands Its Reseller Agreement with Primum Pharma into the MEA Market

6.40 Jan 22, 2024: Avacta Group Announces Issue of Equity and Total Voting Rights

6.41 Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024

6.42 Dec 21, 2023: Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference

6.43 Dec 12, 2023: Nusano to Host December 19 Virtual KOL Event on Emerging Trends in Radiotherapeutics

6.44 Dec 06, 2023: PrecisePK Pioneers Model-Informed Precision Dosing and Pharmacokinetics Advancements in Argentina with Maza University

6.45 Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

Therapeutic Drug Monitoring – Pipeline Products by Segment

Therapeutic Drug Monitoring – Pipeline Products by Territory

Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path

Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date

Therapeutic Drug Monitoring – Ongoing Clinical Trials

Therapeutic Drug Monitoring Companies – Pipeline Products by Stage of Development

Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview

PredicTOR Breast Test – Product Status

PredicTOR Breast Test – Product Description

Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

Methotrexate Chemiluminescent Assay – Product Status

Methotrexate Chemiluminescent Assay – Product Description

Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview

Immune System Profiling – Measure Of Vaccine Efficacy – Product Status

Immune System Profiling – Measure Of Vaccine Efficacy – Product Description

Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview

Locking Assay – Posaconazole – Product Status

Locking Assay – Posaconazole – Product Description

Phage-Based Assay – Product Status

Phage-Based Assay – Product Description

Age Labs AS Pipeline Products & Ongoing Clinical Trials Overview

Drug Response Prediction Test – Rheumatoid Arthritis – Product Status

Drug Response Prediction Test – Rheumatoid Arthritis – Product Description

Animated Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview

ONCO4D Assay – Product Status

ONCO4D Assay – Product Description

Applied Research using OMIC Sciences SL Pipeline Products & Ongoing Clinical Trials Overview

SNP-Test – Product Status

SNP-Test – Product Description

ARK Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

ARK Apixaban Assay – Product Status

ARK Apixaban Assay – Product Description

ARK Atazanavir Assay – Product Status

ARK Atazanavir Assay – Product Description

ARK Dabigatran Assay – Product Status

ARK Dabigatran Assay – Product Description

ARK Darunavir Assay – Product Status

ARK Darunavir Assay – Product Description

ARK Dolutegravir Assay – Product Status

ARK Dolutegravir Assay – Product Description

ARK Edoxaban Assay – Product Status

ARK Edoxaban Assay – Product Description

ARK High Sensitivity Opiates Assay – Product Status

ARK High Sensitivity Opiates Assay – Product Description

ARK Indinavir Assay – Product Status

ARK Indinavir Assay – Product Description

ARK Lopinavir Assay – Product Status

ARK Lopinavir Assay – Product Description

ARK Maraviroc Assay – Product Status

ARK Maraviroc Assay – Product Description

ARK Nelfinavir Assay – Product Status

ARK Nelfinavir Assay – Product Description

ARK Nevirapine Assay – Product Status

ARK Nevirapine Assay – Product Description

ARK Perampanel Assay – Product Status

ARK Perampanel Assay – Product Description

ARK Rivaroxaban Assay – Product Status

ARK Rivaroxaban Assay – Product Description

ARK Saquinavir Assay – Product Status

ARK Saquinavir Assay – Product Description

ARK Tiagabine Assay – Product Status

ARK Tiagabine Assay – Product Description

ARK Zolpidem Assay – Product Status

ARK Zolpidem Assay – Product Description

ARK Zopiclone Assay – Product Status

ARK Zopiclone Assay – Product Description

Avacta Group Plc Pipeline Products & Ongoing Clinical Trials Overview

Depression Test – Product Status

Depression Test – Product Description

Diagnostic Assay – Alzheimer’s Disease – Product Status

Diagnostic Assay – Alzheimer’s Disease – Product Description

Diagnostic Test – ADHD – Product Status

Diagnostic Test – ADHD – Product Description

Diagnostic Test – Bipolar Disorder – Product Status

Diagnostic Test – Bipolar Disorder – Product Description

Schizophrenia Response Test – Product Status

Schizophrenia Response Test – Product Description

Schizophrenia Side Effects Test – Product Status

Schizophrenia Side Effects Test – Product Description

BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview

Avandia Response – Product Status

Avandia Response – Product Description

Biomarker Test – Enbrel – Product Status

Biomarker Test – Enbrel – Product Description

Biomarker Test – Humira – Product Status

Biomarker Test – Humira – Product Description

Biomarker Test – Remicade – Product Status

Biomarker Test – Remicade – Product Description

BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview

Immunobiogram – Renal Transplantation – Product Status

Immunobiogram – Renal Transplantation – Product Description

Boston University Pipeline Products & Ongoing Clinical Trials Overview

ELISA Assay – Tenofovir – Product Status

ELISA Assay – Tenofovir – Product Description

CCC Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

DirectHit Drug Response Indicator Test Panel – Gastrointestinal Cancer – Product Status

DirectHit Drug Response Indicator Test Panel – Gastrointestinal Cancer – Product Description

Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview

Azacitidine Resistance Assay – Product Status

Azacitidine Resistance Assay – Product Description

Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

Therapeutic Monitoring Test – Pancreatic Cancer – Product Status

Therapeutic Monitoring Test – Pancreatic Cancer – Product Description

Cognizance Biomarkers LLC Pipeline Products & Ongoing Clinical Trials Overview

Blood Assay – mTOR Signaling – Product Status

Blood Assay – mTOR Signaling – Product Description

Columbia University Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Acetylcholinesterase (AChE) Activity – Product Status

Diagnostic Assay – Acetylcholinesterase (AChE) Activity – Product Description

ContraVac Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

SpermCheck – Contraception – Product Status

SpermCheck – Contraception – Product Description

Denovo Biolabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

DeQuanto Trastuzumab (Herceptin) PK ELISA KIT – Product Status

DeQuanto Trastuzumab (Herceptin) PK ELISA KIT – Product Description

DNAPrint Genomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Acenome – Product Status

Acenome – Product Description

Melphalan/Topotecan Response Test – Product Status

Melphalan/Topotecan Response Test – Product Description

Statinome – Product Status

Statinome – Product Description

Dublin City University Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Based Test – Multiple Myeloma – Product Status

Biomarker Based Test – Multiple Myeloma – Product Description

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview

Portable Biosensor – Product Status

Portable Biosensor – Product Description

ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview

Eon 300 Automated Chemistry Analyzer – TxB Cardio Assay – Product Status

Eon 300 Automated Chemistry Analyzer – TxB Cardio Assay – Product Description

Eon Digoxin Assay – Product Status

Eon Digoxin Assay – Product Description

Eon Theophylline Assay – Product Status

Eon Theophylline Assay – Product Description

Phenobarbital Assay – Product Status

Phenobarbital Assay – Product Description

Phenytoin Assay – Product Status

Phenytoin Assay – Product Description

Selectra ProM Chemistry System – TxB Cardio Assay – Product Status

Selectra ProM Chemistry System – TxB Cardio Assay – Product Description

Selectra ProS Chemistry System – TxB Cardio Assay – Product Status

Selectra ProS Chemistry System – TxB Cardio Assay – Product Description

Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview

Therapeutic Drug Monitoring Test – Resistant Cancer – Product Status

Therapeutic Drug Monitoring Test – Resistant Cancer – Product Description

Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Cisplatin Chemoresistance Test – Product Status

Cisplatin Chemoresistance Test – Product Description

Prognostic Test – Irinotecan Chemoresistance – Product Status

Prognostic Test – Irinotecan Chemoresistance – Product Description

GenMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

2D6 Tamoxifen Metabolism Test – Product Status

2D6 Tamoxifen Metabolism Test – Product Description

eSensor 2C19 Genotyping Test – Product Status

eSensor 2C19 Genotyping Test – Product Description

GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview

Point-Of-Care Therapeutic Drug Monitoring System – Product Status

Point-Of-Care Therapeutic Drug Monitoring System – Product Description

HORIBA ABX SAS Pipeline Products & Ongoing Clinical Trials Overview

ABX Pentra 400 Analyzer – TDM Assay – Product Status

ABX Pentra 400 Analyzer – TDM Assay – Product Description

Pentra C200 Analyzer – TDM Assay – Product Status

Pentra C200 Analyzer – TDM Assay – Product Description

Inflammatix Inc Pipeline Products & Ongoing Clinical Trials Overview

HostDxTNFresponse – Product Status

HostDxTNFresponse – Product Description

Instrumentation Laboratory Co (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

HemosIL Dabigatran Assay – Product Status

HemosIL Dabigatran Assay – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Predictive Test – Chemotherapy Regimen – Product Status

Predictive Test – Chemotherapy Regimen – Product Description

Magnasense AB Pipeline Products & Ongoing Clinical Trials Overview

Saliva Based Test – Therapeutic Drug Monitoring – Product Status

Saliva Based Test – Therapeutic Drug Monitoring – Product Description

McMaster University Pipeline Products & Ongoing Clinical Trials Overview

Anti-factor Xa Direct Oral Anticoagulants Assay – Product Status

Anti-factor Xa Direct Oral Anticoagulants Assay – Product Description

Point-of-Care Test – TXA – Product Status

Point-of-Care Test – TXA – Product Description

Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Hormone Dependent Tumours – Product Status

Diagnostic Assay – Hormone Dependent Tumours – Product Description

Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview

Cisplatin Tolerance Test – Product Status

Cisplatin Tolerance Test – Product Description

Prostate Cancer TDM Test – Product Status

Prostate Cancer TDM Test – Product Description

Newcastle University Pipeline Products & Ongoing Clinical Trials Overview

Thiopurines Assay – Product Status

Thiopurines Assay – Product Description

Nipro Europe N.V. Pipeline Products & Ongoing Clinical Trials Overview

Lithium Assay – Product Status

Lithium Assay – Product Description

Nuclea Biotechnologies Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

EGFR TK Sensitivity Lung Cancer Diagnostic Test – Product Status

EGFR TK Sensitivity Lung Cancer Diagnostic Test – Product Description

Irinotecan Sensitivity Diagnostic Test – Colon Cancer – Product Status

Irinotecan Sensitivity Diagnostic Test – Colon Cancer – Product Description

PanGenomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Treatment Efficacy Monitoring Assay – Product Status

Treatment Efficacy Monitoring Assay – Product Description

Pax Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

MoodMark Rx – Product Status

MoodMark Rx – Product Description

Pelago Bioscience AB Pipeline Products & Ongoing Clinical Trials Overview

CETSA – Product Status

CETSA – Product Description

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview

Antiobody-Based ELISA Assay – ACTS – Product Status

Antiobody-Based ELISA Assay – ACTS – Product Description

Plateletdiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

pDrp1 Assay – Product Status

pDrp1 Assay – Product Description

Prediction Sciences LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

GeneRx For Hypertension Treatment – Product Status

GeneRx For Hypertension Treatment – Product Description

GeneRx Lithium/Bipolar Test – Product Status

GeneRx Lithium/Bipolar Test – Product Description

Prescient Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Plavix Panel Test – Product Status

Plavix Panel Test – Product Description

Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview

Promonitor – Autoimmune And Inflammation – Product Status

Promonitor – Autoimmune And Inflammation – Product Description

Prometheus Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

PL-200 PredictrPK – CD/UC Infliximab – Product Status

PL-200 PredictrPK – CD/UC Infliximab – Product Description

PL-200 PredictrPK – CD/UC Ustekinumab – Product Status

PL-200 PredictrPK – CD/UC Ustekinumab – Product Description

PL-200 PredictrPK – CD/UC Vedolizumab – Product Status

PL-200 PredictrPK – CD/UC Vedolizumab – Product Description

PL-300 Monitr – Product Status

PL-300 Monitr – Product Description

PL-400 CD/UC Infliximab/Adalimumab – Product Status

PL-400 CD/UC Infliximab/Adalimumab – Product Description

PL-600 Anser CD Risankizumab – Product Status

PL-600 Anser CD Risankizumab – Product Description

PredictrPK ADA – Product Status

PredictrPK ADA – Product Description

Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Promonitor-Anti-CZP (Certolizumab) – Product Status

Promonitor-Anti-CZP (Certolizumab) – Product Description

Promonitor-Anti-TCZ (Tocilizumab) – Product Status

Promonitor-Anti-TCZ (Tocilizumab) – Product Description

Promonitor-CZP (Certolizumab) – Product Status

Promonitor-CZP (Certolizumab) – Product Description

Promonitor-TCZ (Tocilizumab) – Product Status

Promonitor-TCZ (Tocilizumab) – Product Description

Purdue University Pipeline Products & Ongoing Clinical Trials Overview

Point-Of-Care Mass Spectrometry Analysis System – Product Status

Point-Of-Care Mass Spectrometry Analysis System – Product Description

Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview

Hepatocyte – Based Drug Screen Assay – Product Status

Hepatocyte – Based Drug Screen Assay – Product Description

Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview

Cobas i601 – Amikacin Assay – Product Status

Cobas i601 – Amikacin Assay – Product Description

Cobas i601 – Carbam.epoxide Assay – Product Status

Cobas i601 – Carbam.epoxide Assay – Product Description

Cobas i601 – Carbamazepine Assay – Product Status

Cobas i601 – Carbamazepine Assay – Product Description

Cobas i601 – Cyclosporine Assay – Product Status

Cobas i601 – Cyclosporine Assay – Product Description

Cobas i601 – Everolimus Assay – Product Status

Cobas i601 – Everolimus Assay – Product Description

Cobas i601 – Gabapentin Assay – Product Status

Cobas i601 – Gabapentin Assay – Product Description

Cobas i601 – Gentamicin Assay – Product Status

Cobas i601 – Gentamicin Assay – Product Description

Cobas i601 – Lamotrigine Assay – Product Status

Cobas i601 – Lamotrigine Assay – Product Description

Cobas i601 – Leviteracetam Assay – Product Status

Cobas i601 – Leviteracetam Assay – Product Description

Cobas i601 – Linezolid Assay – Product Status

Cobas i601 – Linezolid Assay – Product Description

Cobas i601 – Meropenem Assay – Product Status

Cobas i601 – Meropenem Assay – Product Description

Cobas i601 – Methotrexate Assay – Product Status

Cobas i601 – Methotrexate Assay – Product Description

Cobas i601 – Mycophenolic Acid Assay – Product Status

Cobas i601 – Mycophenolic Acid Assay – Product Description

Cobas i601 – Mycophenolic Acid Glucuronide Assay – Product Status

Cobas i601 – Mycophenolic Acid Glucuronide Assay – Product Description

Cobas i601 – Phenobarbital Assay – Product Status

Cobas i601 – Phenobarbital Assay – Product Description

Cobas i601 – Phenytoin Assay – Product Status

Cobas i601 – Phenytoin Assay – Product Description

Cobas i601 – Phenytoin Free Assay – Product Status

Cobas i601 – Phenytoin Free Assay – Product Description

Cobas i601 – Piperacillin Assay – Product Status

Cobas i601 – Piperacillin Assay – Product Description

Cobas i601 – Primidone Assay – Product Status

Cobas i601 – Primidone Assay – Product Description

Cobas i601 – Sirolimus Assay – Product Status

Cobas i601 – Sirolimus Assay – Product Description

Cobas i601 – Tacrolimus Assay – Product Status

Cobas i601 – Tacrolimus Assay – Product Description

Cobas i601 – Tobramycin Assay – Product Status

Cobas i601 – Tobramycin Assay – Product Description

Cobas i601 – Topiramate Assay – Product Status

Cobas i601 – Topiramate Assay – Product Description

Cobas i601 – Valproic Acid Assay – Product Status

Cobas i601 – Valproic Acid Assay – Product Description

Cobas i601 – Valproic Acid Free Assay – Product Status

Cobas i601 – Valproic Acid Free Assay – Product Description

Cobas i601 – Vancomycin Assay – Product Status

Cobas i601 – Vancomycin Assay – Product Description

Cobas i601 – Voriconazole Assay – Product Status

Cobas i601 – Voriconazole Assay – Product Description

Cobas i601 – Zonisamide Assay – Product Status

Cobas i601 – Zonisamide Assay – Product Description

Liat Assay – Pharmacogenomics – Product Status

Liat Assay – Pharmacogenomics – Product Description

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview

Cobas – Cyclosporin A Assay – Product Status

Cobas – Cyclosporin A Assay – Product Description

Cobas 6000 Analyzer Series With c 501 Module – Cyclosporine Assay – Product Status

Cobas 6000 Analyzer Series With c 501 Module – Cyclosporine Assay – Product Description

Cobas 6000 Analyzer Series With c 501 Module – Lidocaine Assay – Product Status

Cobas 6000 Analyzer Series With c 501 Module – Lidocaine Assay – Product Description

Cobas 6000 Analyzer Series With c 501 Module – Tacrolimus Assay – Product Status

Cobas 6000 Analyzer Series With c 501 Module – Tacrolimus Assay – Product Description

Cobas 6000 Analyzer Series With e 601 Module – Cyclosporine Assay – Product Status

Cobas 6000 Analyzer Series With e 601 Module – Cyclosporine Assay – Product Description

Cobas 6000 Analyzer Series With e 601 Module – Everolimus Assay – Product Status

Cobas 6000 Analyzer Series With e 601 Module – Everolimus Assay – Product Description

Cobas 6000 Analyzer Series With e 601 Module – Sirolimus Assay – Product Status

Cobas 6000 Analyzer Series With e 601 Module – Sirolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 502 Module – Everolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 502 Module – Everolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 502 Module – Lidocaine Assay – Product Status

Cobas 8000 Analyzer Series With c 502 Module – Lidocaine Assay – Product Description

Cobas 8000 Analyzer Series With c 502 Module – Sirolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 502 Module – Sirolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 502 Module – Tacrolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 502 Module – Tacrolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 701 Module – Everolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 701 Module – Everolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 701 Module – Lidocaine Assay – Product Status

Cobas 8000 Analyzer Series With c 701 Module – Lidocaine Assay – Product Description

Cobas 8000 Analyzer Series With c 701 Module – Sirolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 701 Module – Sirolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 701 Module – Tacrolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 701 Module – Tacrolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 702 Module – Everolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 702 Module – Everolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 702 Module – Lidocaine Assay – Product Status

Cobas 8000 Analyzer Series With c 702 Module – Lidocaine Assay – Product Description

Cobas 8000 Analyzer Series With c 702 Module – Sirolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 702 Module – Sirolimus Assay – Product Description

Cobas 8000 Analyzer Series With c 702 Module – Tacrolimus Assay – Product Status

Cobas 8000 Analyzer Series With c 702 Module – Tacrolimus Assay – Product Description

Cobas 8000 Analyzer Series With e 602 Module – Everolimus Assay – Product Status

Cobas 8000 Analyzer Series With e 602 Module – Everolimus Assay – Product Description

Cobas 8000 Analyzer Series With e 602 Module – Lidocaine Assay – Product Status

Cobas 8000 Analyzer Series With e 602 Module – Lidocaine Assay – Product Description

Cobas 8000 Analyzer Series With e 801 Module – Everolimus Assay – Product Status

Cobas 8000 Analyzer Series With e 801 Module – Everolimus Assay – Product Description

Cobas 8000 Analyzer Series With e 801 Module – Tacrolimus Assay – Product Status

Cobas 8000 Analyzer Series With e 801 Module – Tacrolimus Assay – Product Description

Cobas c 303 System – Quinidine Assay – Product Status

Cobas c 303 System – Quinidine Assay – Product Description

Cobas c 503 System – Quinidine Assay – Product Status

Cobas c 503 System – Quinidine Assay – Product Description

Cobas t 511 Coagulation Analyzer – Apixaban Assay – Product Status

Cobas t 511 Coagulation Analyzer – Apixaban Assay – Product Description

Cobas t 511 Coagulation Analyzer – Dabigatran Assay – Product Status

Cobas t 511 Coagulation Analyzer – Dabigatran Assay – Product Description

Cobas t 511 Coagulation Analyzer – Rivaroxaban Assay – Product Status

Cobas t 511 Coagulation Analyzer – Rivaroxaban Assay – Product Description

Cobas t 711 Coagulation Analyzer – Apixaban Assay – Product Status

Cobas t 711 Coagulation Analyzer – Apixaban Assay – Product Description

Cobas t 711 Coagulation Analyzer – Dabigatran Assay – Product Status

Cobas t 711 Coagulation Analyzer – Dabigatran Assay – Product Description

Cobas t 711 Coagulation Analyzer – Rivaroxaban Assay – Product Status

Cobas t 711 Coagulation Analyzer – Rivaroxaban Assay – Product Description

Integrated Modular Analytics – Tacrolimus Test – Product Status

Integrated Modular Analytics – Tacrolimus Test – Product Description

Integrated Modular Analytics System – Mycophenolic Acid Test – Product Status

Integrated Modular Analytics System – Mycophenolic Acid Test – Product Description

Rockland Immunochemicals Inc Pipeline Products & Ongoing Clinical Trials Overview

Akt/mTOR Signaling Pharmacodynamics Assay – Product Status

Akt/mTOR Signaling Pharmacodynamics Assay – Product Description

SAGA Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

SAGAsign – Therapy Response Monitoring & Drug Resistance – Product Status

SAGAsign – Therapy Response Monitoring & Drug Resistance – Product Description

Saladax Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

MyCare Assay – Busulfan – Product Status

MyCare Assay – Busulfan – Product Description

MyCare Assay – Cyclophosphamide – Product Status

MyCare Assay – Cyclophosphamide – Product Description

MyCare Assay – Doxorubicin – Product Status

MyCare Assay – Doxorubicin – Product Description

MyCare Assay – Gemcitabine – Product Status

MyCare Assay – Gemcitabine – Product Description

MyCare Assay – Irinotecan – Product Status

MyCare Assay – Irinotecan – Product Description

MyCare Assay – Lenalidomide – Product Status

MyCare Assay – Lenalidomide – Product Description

MyCare Assay – Thalidomide – Product Status

MyCare Assay – Thalidomide – Product Description

MyCare Assay – Tyrosine Kinase Inhibitor – Product Status

MyCare Assay – Tyrosine Kinase Inhibitor – Product Description

MyCare Assay – Vincristine – Product Status

MyCare Assay – Vincristine – Product Description

MyCare Psychiatry Aripiprazole Assay Kit – Product Status

MyCare Psychiatry Aripiprazole Assay Kit – Product Description

MyCare Psychiatry Olanzapine Assay Kit – Product Status

MyCare Psychiatry Olanzapine Assay Kit – Product Description

MyCare Psychiatry Quetiapine Assay Kit – Product Status

MyCare Psychiatry Quetiapine Assay Kit – Product Description

MyCare Psychiatry Total Risperidone Assay Kit – Product Status

MyCare Psychiatry Total Risperidone Assay Kit – Product Description

Nanoparticle Immunoassay Kit – TDM – Product Status

Nanoparticle Immunoassay Kit – TDM – Product Description

Saladax Biomedical Inc – Ongoing Clinical Trials Overview

MyCare Assay – Busulfan – Collection of Plasma Samples Using Sodium Heparin From Subjects Undergoing Intravenous Busulfan Treatment

Sanofi Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Assay – Metformin Efficacy – Product Status

Biomarker Assay – Metformin Efficacy – Product Description

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

ADVIA Centaur CP Immunoassay System – Everolimus Assay – Product Status

ADVIA Centaur CP Immunoassay System – Everolimus Assay – Product Description

ADVIA Centaur CP Immunoassay System – Sirolimus Assay – Product Status

ADVIA Centaur CP Immunoassay System – Sirolimus Assay – Product Description

ADVIA Centaur XP Immunoassay System – Everolimus Assay – Product Status

ADVIA Centaur XP Immunoassay System – Everolimus Assay – Product Description

ADVIA Centaur XP Immunoassay System – Sirolimus Assay – Product Status

ADVIA Centaur XP Immunoassay System – Sirolimus Assay – Product Description

ADVIA Centaur XP Immunoassay System – Tacrolimus Assay – Product Status

ADVIA Centaur XP Immunoassay System – Tacrolimus Assay – Product Description

ADVIA Centaur XPT Immunoassay System – Everolimus Assay – Product Status

ADVIA Centaur XPT Immunoassay System – Everolimus Assay – Product Description

ADVIA Centaur XPT Immunoassay System – Sirolimus Assay – Product Status

ADVIA Centaur XPT Immunoassay System – Sirolimus Assay – Product Description

ADVIA Centaur XPT Immunoassay System – Tacrolimus Assay – Product Status

ADVIA Centaur XPT Immunoassay System – Tacrolimus Assay – Product Description

ADVIA Tacrolimus Assay – Product Status

ADVIA Tacrolimus Assay – Product Description

Atellica IM Analyzer – Everolimus Assay – Product Status

Atellica IM Analyzer – Everolimus Assay – Product Description

Atellica IM Analyzer – Sirolimus Assay – Product Status

Atellica IM Analyzer – Sirolimus Assay – Product Description

Atellica Solution – Gabapentin Assay – Product Status

Atellica Solution – Gabapentin Assay – Product Description

Atellica Solution – Tacrolimus Assay – Product Status

Atellica Solution – Tacrolimus Assay – Product Description

Atellica Solution – Voriconazole Assay – Product Status

Atellica Solution – Voriconazole Assay – Product Description

Atellica Solution Clinical Chemistry Analyzer – Levetiracetam – Product Status

Atellica Solution Clinical Chemistry Analyzer – Levetiracetam – Product Description

Sirius Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview

Pharmacogenetic Test – Product Status

Pharmacogenetic Test – Product Description

Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview

Blood-Based Immunoassay – Oral Anticoagulants – Product Status

Blood-Based Immunoassay – Oral Anticoagulants – Product Description

SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Ig_PLEX TNF Assay – Product Status

Ig_PLEX TNF Assay – Product Description

Multiplex Anti Drug Antibody Assay – Product Status

Multiplex Anti Drug Antibody Assay – Product Description

T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview

T2Endotoxin – Product Status

T2Endotoxin – Product Description

Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

Cascadion SM Clinical Analyzer – Therapeutic Drug Monitoring – Product Status

Cascadion SM Clinical Analyzer – Therapeutic Drug Monitoring – Product Description

TrivarX Ltd Pipeline Products & Ongoing Clinical Trials Overview

Medibio RX – Bipolar – Product Status

Medibio RX – Bipolar – Product Description

Medibio RX – General Anxiety Disorders – Product Status

Medibio RX – General Anxiety Disorders – Product Description

Medibio RX – PTSD – Product Status

Medibio RX – PTSD – Product Description

Medibio RX – Schizophrenia – Product Status

Medibio RX – Schizophrenia – Product Description

Universidade Feevale Pipeline Products & Ongoing Clinical Trials Overview

Dried Plasma Spot Assay – Therapeutic Drug Monitoring – Product Status

Dried Plasma Spot Assay – Therapeutic Drug Monitoring – Product Description

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Assay – Schizophrenia – Product Status

Biomarker Assay – Schizophrenia – Product Description

Pharmacokinetic Drug Monitoring Device – Product Status

Pharmacokinetic Drug Monitoring Device – Product Description

University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview

Therapeutic Drug Monitoring Test – HIV – Product Status

Therapeutic Drug Monitoring Test – HIV – Product Description

University of North Dakota Pipeline Products & Ongoing Clinical Trials Overview

Screening Assay – Anti Viral Drug – Product Status

Screening Assay – Anti Viral Drug – Product Description

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview

Theranostic Assay – Squamous Cell Carcinoma – Product Status

Theranostic Assay – Squamous Cell Carcinoma – Product Description

University of Sao Paulo Pipeline Products & Ongoing Clinical Trials Overview

Portable Sensor – Product Status

Portable Sensor – Product Description

University of Utah Pipeline Products & Ongoing Clinical Trials Overview

Anti-TNF Drug Monitoring Immunoassay – Product Status

Anti-TNF Drug Monitoring Immunoassay – Product Description

University of Washington Pipeline Products & Ongoing Clinical Trials Overview

Point-Of-Care Assay – Tenofovir – Product Status

Point-Of-Care Assay – Tenofovir – Product Description

Vesynta Ltd Pipeline Products & Ongoing Clinical Trials Overview

ChromaDose – Product Status

ChromaDose – Product Description

Vyant Bio Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Comprehensive Pharmacogenomics Panel Test – Product Status

Comprehensive Pharmacogenomics Panel Test – Product Description

Zymeron Corp Pipeline Products & Ongoing Clinical Trials Overview

Rapid Point of Care Test – Antiretroviral Drug Adherence Monitoring – Product Status

Rapid Point of Care Test – Antiretroviral Drug Adherence Monitoring – Product Description

Therapeutic Drug Monitoring Test – Tuberculosis – Product Status

Therapeutic Drug Monitoring Test – Tuberculosis – Product Description

Glossary

Figures

Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

Therapeutic Drug Monitoring – Pipeline Products by Segment

Therapeutic Drug Monitoring – Pipeline Products by Territory

Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path

Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date

Therapeutic Drug Monitoring – Ongoing Clinical Trials

Frequently asked questions

Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Therapeutic Drug Monitoring reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more